Table 3 Summary of HIV-HCV Co-infection among clients in MMT in China
Groups | Provinces | No of studies | Study Year | Prevalence (individual studies) (95% CI) | Pooled prevalence (provinces) (95%CI) | Pooled prevalence (group) (95% CI) |
|---|---|---|---|---|---|---|
HTAs | Guangxi | 3 | Â | Â | 12.6% (4.0-33.4%) | 8.0% (4.8-12.9%) |
 Zhou XP, 2009 [31] |  | 2007 | 11.2% (7.2-16.9%) |  | ||
 Chang ZR, 2010 [32] |  | 2008 | 27.4% (24.7-30.2%) |  | ||
 Bai Y, 2009 [33] |  | 2009 | 5.8% (4.1-8.2%) |  | ||
| Â | Guizhou | 3 | Â | Â | 3.8% (0.4-29.3%) | |
 Chang ZR, 2010 [32] |  | 2008 | 23.1% (20.0-26.5%) |  | ||
 Wang J, 2010 [36] |  | 2009 | 0.7% (0.1-4.8%) |  | ||
 Han XJ, 2010 [34] |  | 2009 | 2.0% (0.9-4.4%) |  | ||
| Â | Sichuan | 4 | Â | Â | 6.8% (2.8-15.8%) | |
 Qian HZ, 2007 [38] |  | 2005 | 13.5% (10.9-16.6%) |  | ||
 Dong G, 2009 [41] |  | 2007 | 3.4% (2.0-5.9%) |  | ||
 Wang DY, 2010 [120] |  | 2008 | 19.2% (16.4-22.3%) |  | ||
 Yao W, 2008 [44] |  | 2008 | 1.9% (1.1-3.2%) |  | ||
LTAs | Chongqing | 2 | Â | Â | 5.3% (1.9-13.9%) | 2.5% (1.4-4.4%) |
 Zhou X, 2009 [60] |  | 2007 | 8.7% (6.6-11.2%) |  | ||
 Wu GH, 2010 [59] |  | 2008 | 3.1% (2.1-4.5%) |  | ||
| Â | Fujian | 1 | Â | Â | 1.0% (0.1-6.8%) | |
 Wu LH, 2007 [61] |  | 2006 | 1.0% (0.1-6.8%) |  | ||
| Â | Gansu | 1 | Â | Â | 0.8% (0.2-3.2%) | |
 Gao LF, 2010 [63] |  | 2009 | 0.8% (0.2-3.2%) |  | ||
| Â | Guangdong | 2 | Â | Â | 1.9% (0.9-3.8%) | |
 Li YF, 2009 [72] |  | 2008 | 2.5% (1.0-5.9%) |  | ||
 Xia L, 2010 [77] |  | 2009 | 1.2% (0.4-3.7%) |  | ||
| Â | Henan | 1 | Â | Â | 0.5% (0.1-3.2%) | |
 Wu SX, 2009 [78] |  | 2008 | 0.5% (0.1-3.2%) |  | ||
| Â | Hunan | 1 | Â | Â | 6.8% (4.8-9.4%) | |
 Chen LF, 2009 [83] |  | 2009 | 6.8% (4.8-9.4%) |  | ||
| Â | Jiangsu | 1 | Â | Â | 1.0% (0.2-3.7%) | |
|  |  Wang YP, 2009 [87] |  | 2007 | 1.0% (0.2-3.7%) |  |  |